Airdoc

Airdoc was founded in September 2015 as a medical artificial intelligence enterprise, headquartered in Beijing. Since its inception, it has attracted significant capital, cumulatively receiving multiple rounds of investment from renowned institutions such as CITIC, Ping An, and Fosun. It has established deep cooperation with numerous medical institutions globally, with R&D centers and branch offices in Beijing, Shanghai, Guangzhou, and Seattle, and a joint laboratory established with Monash University in Melbourne.


The company's independently developed AI detection solutions can accurately identify risks of dozens of cardiovascular, neurological, endocrine system, and eye diseases or complications through retinal images. As a pioneer in the health AI field to achieve commercial product implementation, the company has successfully served over a thousand sites domestically and internationally, including public medical institutions, optometric chain organizations, physical examination centers, and insurance companies.

The company continues to practice its vision of "Making Health Ubiquitous" and has achieved advanced results in areas such as visual health, electrocardiography, electroencephalography, dermatology, continuous physiological monitoring, medical imaging, and pathology, with over 70 patent applications filed. To date, the company has achieved vertical commercial development centered on retinal AI detection, while horizontally forming a product pipeline, adhering to a "one vertical, one horizontal" strategy, ultimately aiming to provide inclusive health services to the public.